FAQ
Psychiatric Medication Management
Psychiatric medication management involves evaluating symptoms, prescribing appropriate medications, and monitoring treatment over time. At Sacramento NeuroPsych Associates, this process is collaborative and individualized, focusing on safety, effectiveness, and long-term improvement in quality of life. Medication management is often combined with other treatment approaches as part of comprehensive mental health care.
What is psychiatric medication management?
Psychiatric medication management includes the assessment, prescription, and ongoing monitoring of medications used to treat mental health conditions.
Who provides psychiatric medication management?
Medication management is provided by qualified mental health professionals, including psychiatrists and psychiatric nurse practitioners.
What mental health conditions are treated through medication management?
Medication management may be used for conditions such as depression, anxiety disorders, bipolar disorder, schizophrenia, and ADHD, depending on individual needs.
How is the right medication determined?
Treatment decisions are based on symptoms, medical history, prior treatment response, and ongoing monitoring, with adjustments made as needed over time.
Can medications be adjusted or combined with therapy?
Yes. Medications are commonly adjusted as treatment progresses and are often used alongside psychotherapy for more comprehensive care.
View full medication management details here
Transcranial Magnetic Stimulation (TMS) for Treatment Resistant Depression (TRD)
Transcranial Magnetic Stimulation (TMS) is an FDA-cleared, non-invasive treatment used for individuals with depression and other conditions who have not responded adequately to medications. It uses targeted magnetic pulses to stimulate areas of the brain involved in mood regulation and is performed in-office while the patient remains awake and alert.
What is TMS therapy?
TMS is a non-invasive procedure that uses magnetic fields to stimulate nerve cells in specific brain regions associated with mood and behavior.
Is TMS FDA-approved?
Yes. TMS has been FDA-cleared for the treatment of major depressive disorder and is widely used for treatment-resistant depression.
How long does TMS treatment take?
A typical course consists of daily weekday sessions over several weeks. Individual sessions are relatively short and performed entirely in-office.
What does TMS feel like?
Patients may feel a tapping sensation on the scalp and hear clicking sounds during treatment. Most side effects are mild and temporary.
Is TMS covered by insurance?
Many insurance plans cover TMS for treatment-resistant depression, though prior authorization is often required.
View full TMS treatment details here
Spravato (esketamine) as a treatment for Treatment-Resistant Depression (TRD)
Spravato® (esketamine) is an FDA-approved nasal spray used to treat adults with treatment-resistant depression under medical supervision. It works differently than traditional antidepressants and must be administered in a certified clinical setting with post-treatment monitoring.
What is Spravato®?
Spravato® is a prescription nasal spray containing esketamine, approved by the FDA for adults with treatment-resistant depression.
Who qualifies for Spravato treatment?
Spravato is intended for adults who have not responded adequately to at least two antidepressant medications, as determined by a healthcare provider.
How is Spravato administered?
Patients self-administer the nasal spray in a certified treatment center under medical supervision.
What does treatment involve?
After dosing, patients are monitored in-office for at least two hours to observe for side effects and ensure safety.
Is Spravato covered by insurance?
Coverage varies by plan, but many insurers provide coverage when medical criteria are met and prior authorization is obtained.
View full Spravato treatment details here
Always consult with a qualified healthcare professional for personalized information and advice related to Spravato and its potential benefits for treating Treatment-Resistant Depression (TRD).